SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to a significant drop, driven by the expiration of a lock-up period, making a large number of shares available for sale; the community is debating whether this presents a buying opportunity or signals deeper issues, with some pointing to potential insider selling and comparing it to other struggling fintech companies. The high trading volume and price volatility are fueling discussions about potential manipulation and future prospects.

American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.

American Rebel Holdings Inc

AREB is trending due to a proposed reverse stock split with a unique "round lot protection" clause, sparking mixed reactions; some see it as a buying opportunity, while others fear dilution. Community discussions revolve around the mechanics of the split, its potential impact on share value, and whether it's a strategic move or a sign of underlying issues. Speculation about short squeezes and potential for gains/losses is rampant amid the volatility.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending due to community discussion around its potential for a short squeeze, noting high short interest and unusual options activity. Some view it as a leading AI biotech play with significant upside, while others cite concerns about cash burn and insider selling. Optimism remains around potential catalysts, partnerships, and upcoming clinical data.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently closed $75 million investment focused on AI connectivity, fueling speculation about the institutional investor behind the deal and potential strategic implications for the company. Community discussions revolve around POET's role in addressing bottlenecks in AI data centers and the potential for partnerships or M&A activity in the AI hardware space. Bullish sentiment is high, with many anticipating significant upside potential and comparing it to other high-growth tech sectors.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital (ATON) is trending due to its focus on tokenizing its mesothelioma treatment program and merging blockchain technology with cancer therapeutics, sparking debate about the company's direction. Community discussions revolve around potential pump-and-dump schemes and the stock's volatility, while some see opportunity in its unique approach to decentralized science. ATON's movements are also being compared to other volatile stocks like XBIO, NXL and ECDA, with traders actively seeking the next high-potential runner.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid renewed buyout speculation and anticipation for upcoming trial catalysts, especially following competitor acquisitions in the obesity and NASH space. Community members highlight VKTX's strong pipeline, potential for best-in-class efficacy, and a growing sense that the market is undervaluing the stock relative to recent deals. A possible short squeeze due to high short interest also fuels interest.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential for a short squeeze, citing a small float and high short interest. The community is also focused on upcoming data releases and potential partnerships, viewing the stock as undervalued within the cancer immunotherapy sector. Some are expressing frustration with the stock's performance despite positive clinical data.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is trending as investors discuss its potential for a short squeeze given the high short interest and recent insider buying, while others are anticipating news from upcoming conferences. Bullish sentiment is fueled by the long-term potential of gene editing and CRISPR's diverse pipeline, including its commercial success with Casgevy. Some traders are eyeing resistance levels, speculating on trial breakthroughs, and monitoring for analyst upgrades as potential catalysts.

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences Inc

XBIO is trending as traders discuss the potential for another short squeeze, drawing comparisons to other recent high-flying low float biotech stocks. Community members are actively speculating on potential price targets and entry points, while also noting the company's expanded R&D collaboration with The Scripps Research Institute. Some caution against FOMO (fear of missing out) and highlight the stock's volatility.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as investors flock to the safe-haven asset amid concerns about the government shutdown and broader economic uncertainty. Community chatter highlights gold's potential to reach new highs, with some viewing it as a hedge against potential market downturns or a declining dollar. Discussions also include the relationship between gold, equities, and crypto.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


88CLBGL

88CLB GLCOM